TEL: +86 571 56623320 EMAIL: [email protected]
Product Name HHV8 ORF50 Chinese Name 人类疱疹病毒8抗体 Alias Putative transcription activator ORF50; ORF50; ORF50_HHV8P; literatures Specific References (1) | SL0746R has been referenced in 1 publications.[IF=20.693] Myung-Ju Lee. et al. CXCL1 confers a survival advantage in Kaposi's sarcoma-associated herpesvirus-infected human endothelial cells through STAT3 phosphorylation. J MED VIROL. 2022 Jul;: WB ; Human.Research Area Tumour immunology Bacteria and viruses Immunogen Species Rabbit Clonality Polyclonal Applications ELISA=1:5000-10000
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.Theoretical molecular weight 74kDa Form Liquid Concentration 1mg/ml immunogen KLH conjugated synthetic peptide derived from HHV8 ORF50: 2-100/691 Lsotype IgG Purification affinity purified by Protein A Buffer Solution 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. Storage Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. Attention This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. PubMed PubMed Product Detail HHV8 has been found to be associated with three different diseases observed in AIDS patients; kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
SWISS:
F5HCV3
Gene ID:
4961526
Database links:GeneID:4961526
SwissProt: F5HCV3 Human herpesvirus 8
学者研究认为:包括HHV-8在内的一类疱疹病毒THC(Herpesviruses)都存在ORF50基因的诱导,ORF50能够靶向这类病毒。
Scan Wechat Qrcode